Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
284 | Advances in Pharmacological Sciences | journal | 0.862 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
283 | Australian Journal of Pharmacy | journal | 0.102 Q4 | 5 | 0 | 130 | 0 | 5 | 110 | 0.15 | 0.00 | 0.00 | |
282 | Circular Farmaceutica | journal | 0.100 Q4 | 3 | 0 | 71 | 0 | 0 | 65 | 0.00 | 0.00 | 0.00 | |
281 | Clinical Pharmacist | journal | 0.109 Q4 | 11 | 0 | 266 | 0 | 38 | 225 | 0.08 | 0.00 | 0.00 | |
280 | Drug Discoveries and Therapeutics | journal | 0.261 Q3 | 31 | 0 | 31 | 0 | 56 | 30 | 7.00 | 0.00 | 0.00 | |
279 | Frontiers in Clinical Drug Research - Alzheimer Disorders | book series | 0.248 Q3 | 3 | 0 | 7 | 0 | 4 | 1 | 0.57 | 0.00 | 0.00 | |
278 | Frontiers in Clinical Drug Research - Anti Allergy Agents | book series | 0.109 Q4 | 1 | 0 | 13 | 0 | 2 | 5 | 0.15 | 0.00 | 0.00 | |
277 | Journal fur Pharmakologie und Therapie | journal | 0.101 Q4 | 2 | 0 | 91 | 0 | 0 | 50 | 0.00 | 0.00 | 0.00 | |
276 | P and T | journal | 0.658 Q2 | 63 | 0 | 181 | 0 | 382 | 72 | 1.53 | 0.00 | 0.00 | |
275 | Pharmaceutical Technology in Hospital Pharmacy | journal | 0.130 Q4 | 1 | 0 | 3 | 0 | 2 | 3 | 0.67 | 0.00 | 0.00 | |
274 | Pharmacien Hospitalier et Clinicien | journal | 0.218 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
273 | Synergy | journal | 0.275 Q3 | 15 | 0 | 28 | 0 | 69 | 27 | 1.17 | 0.00 | 0.00 | |
272 | OpenNano | journal | 0.932 Q1 | 21 | 2 | 12 | 106 | 151 | 12 | 10.00 | 53.00 | 50.00 | |
271 | Japanese Pharmacology and Therapeutics | journal | 0.115 Q4 | 18 | 3 | 354 | 0 | 50 | 353 | 0.14 | 0.00 | 0.00 | |
270 | Anti-Obesity Drug Discovery and Development | book series | 1 | 5 | 2 | 1128 | 1 | 0 | 0.50 | 225.60 | 0.00 | ||
269 | Drug Target Insights | journal | 0.365 Q3 | 16 | 5 | 12 | 193 | 30 | 11 | 2.60 | 38.60 | 40.00 | |
268 | Oral Therapeutics and Pharmacology | journal | 0.105 Q4 | 6 | 5 | 23 | 128 | 1 | 23 | 0.08 | 25.60 | 34.48 | |
267 | Adverse Drug Reaction Bulletin | journal | 0.124 Q4 | 8 | 6 | 18 | 185 | 8 | 17 | 0.58 | 30.83 | 44.44 | |
266 | Frontiers in Clinical Drug Research - HIV | book series | 1 | 6 | 6 | 695 | 0 | 0 | 0.00 | 115.83 | 55.56 | ||
265 | Open Access Journal of Clinical Trials | journal | 0.785 Q2 | 15 | 6 | 17 | 202 | 16 | 17 | 1.17 | 33.67 | 52.94 | |
264 | Therapeutic Advances in Cardiovascular Disease | journal | 0.816 Q2 | 41 | 10 | 75 | 428 | 201 | 66 | 3.11 | 42.80 | 17.14 | |
263 | Cancer and Chemotherapy Reviews | journal | 0.116 Q4 | 4 | 11 | 21 | 144 | 2 | 19 | 0.00 | 13.09 | 66.67 | |
262 | Journal of Population Therapeutics and Clinical Pharmacology (discontinued) | journal | 0.350 Q3 | 45 | 12 | 71 | 230 | 104 | 66 | 1.62 | 19.17 | 22.86 | |
261 | WHO Drug Information | journal | 0.118 Q4 | 11 | 12 | 26 | 173 | 3 | 21 | 0.10 | 14.42 | 41.18 | |
260 | Frontiers in Clinical Drug Research - Anti Infectives | book series | 0.359 Q3 | 2 | 13 | 14 | 1862 | 8 | 2 | 0.57 | 143.23 | 63.89 | |
259 | Epitheorese Klinikes Farmakologias kai Farmakokinetikes | journal | 0.106 Q4 | 5 | 14 | 65 | 339 | 12 | 64 | 0.21 | 24.21 | 92.31 | |
258 | Journal of Health Policy and Outcomes Research | journal | 1 | 14 | 16 | 351 | 3 | 16 | 0.19 | 25.07 | 56.06 | ||
257 | Pharma-Kritik (discontinued) | journal | 2 | 14 | 53 | 127 | 0 | 33 | 0.00 | 9.07 | 33.33 | ||
256 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 14 | 47 | 677 | 296 | 45 | 6.27 | 48.36 | 48.98 | ||
255 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 13 | 14 | 33 | 623 | 142 | 31 | 3.41 | 44.50 | 46.43 | ||
254 | Topics in antiviral medicine | journal | 1.113 Q1 | 46 | 14 | 47 | 306 | 139 | 43 | 3.45 | 21.86 | 33.33 | |
253 | Current Topics in Pharmacology | journal | 0.121 Q4 | 8 | 15 | 37 | 617 | 9 | 36 | 0.27 | 41.13 | 32.69 | |
252 | International Journal of Breast Cancer | journal | 0.403 Q3 | 23 | 15 | 36 | 492 | 87 | 34 | 2.12 | 32.80 | 41.41 | |
251 | Journal of International Peacekeeping | journal | 0.109 Q4 | 14 | 15 | 33 | 746 | 4 | 30 | 0.21 | 49.73 | 37.50 | |
250 | Medical Cannabis and Cannabinoids | journal | 13 | 15 | 35 | 808 | 153 | 30 | 3.70 | 53.87 | 34.88 | ||
249 | Pharmacological Research - Modern Chinese Medicine | journal | 9 | 15 | 0 | 1000 | 0 | 0 | 0.00 | 66.67 | 47.56 | ||
248 | Journal of Nephropharmacology | journal | 0.177 Q4 | 7 | 18 | 56 | 551 | 33 | 56 | 0.59 | 30.61 | 47.50 | |
247 | Giornale Italiano di Farmacia Clinica | journal | 0.106 Q4 | 8 | 19 | 68 | 289 | 6 | 55 | 0.12 | 15.21 | 67.44 | |
246 | Review of Clinical Pharmacology and Pharmacokinetics, International Edition | journal | 0.101 Q4 | 9 | 19 | 88 | 557 | 7 | 75 | 0.00 | 29.32 | 64.71 | |
245 | ADMET and DMPK | journal | 0.262 Q3 | 21 | 20 | 69 | 968 | 110 | 65 | 1.60 | 48.40 | 45.83 | |
244 | AIDS Reviews | journal | 0.489 Q3 | 62 | 20 | 102 | 725 | 159 | 84 | 1.71 | 36.25 | 33.65 | |
243 | Drug Resistance Updates | journal | 3.845 Q1 | 132 | 21 | 62 | 5642 | 1385 | 62 | 22.11 | 268.67 | 38.94 | |
242 | HIV Research and Clinical Practice | journal | 0.612 Q2 | 54 | 21 | 66 | 917 | 119 | 65 | 1.54 | 43.67 | 45.54 | |
241 | Recent Advances in Anti-Infective Drug Discovery | journal | 0.301 Q3 | 38 | 21 | 44 | 974 | 87 | 38 | 1.40 | 46.38 | 40.96 | |
240 | Current Cardiovascular Risk Reports | journal | 0.424 Q3 | 34 | 22 | 94 | 1361 | 77 | 94 | 0.94 | 61.86 | 35.29 | |
239 | Translational and Clinical Pharmacology | journal | 0.363 Q3 | 12 | 22 | 71 | 635 | 115 | 67 | 1.93 | 28.86 | 44.16 | |
238 | Trends in Immunotherapy | journal | 4 | 22 | 26 | 566 | 11 | 24 | 0.42 | 25.73 | 34.33 | ||
237 | Biomedical and Biopharmaceutical Research | journal | 0.124 Q4 | 4 | 24 | 47 | 682 | 13 | 43 | 0.28 | 28.42 | 67.53 | |
236 | Clinical Pharmacology: Advances and Applications | journal | 0.510 Q3 | 34 | 24 | 62 | 976 | 146 | 59 | 1.93 | 40.67 | 30.77 | |
235 | Drug Metabolism Letters | journal | 0.357 Q3 | 31 | 24 | 34 | 1151 | 66 | 29 | 1.86 | 47.96 | 25.84 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®